how do glp-1 work for weight loss Agonists Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH Why GLP-1 Drugs Alone Aren't

In one study of over 83,000 patients, semaglutide was associated with a 50%-56% lower risk for both incidence and recurrence of alcohol use disorder over a 12-month follow-up compared with other anti-obesity medications

(Note to Congress: Rather than permitting the Food and Drug Administration to stop the work of compounding pharmacies on GLP-1s a throttling that is now well underway please devise a thoughtful generics strategy that prioritizes product availability, quality, patient safety, and an appropriate reward for innovator companies in equal measure.) 3

Citing various estimates, PwC pegged the current GLP-1 market at $133 billion, with the potential to climb to $150 billion by 2030

Xie, Y., Bowe, B

Can I split a larger dose into two injections